1. Home
  2. ZVRA vs EHAB Comparison

ZVRA vs EHAB Comparison

Compare ZVRA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$10.53

Market Cap

472.9M

Sector

Health Care

ML Signal

HOLD

Logo Enhabit Inc.

EHAB

Enhabit Inc.

HOLD

Current Price

$13.72

Market Cap

692.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
EHAB
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.9M
692.9M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ZVRA
EHAB
Price
$10.53
$13.72
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$23.00
$13.84
AVG Volume (30 Days)
665.1K
1.1M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
159.21
97.11
EPS
1.35
N/A
Revenue
$106,470,000.00
$1,060,000,000.00
Revenue This Year
$37.27
$6.42
Revenue Next Year
$53.42
$4.88
P/E Ratio
$7.65
N/A
Revenue Growth
350.91
2.44
52 Week Low
$6.85
$6.47
52 Week High
$13.16
$14.22

Technical Indicators

Market Signals
Indicator
ZVRA
EHAB
Relative Strength Index (RSI) 64.88 54.74
Support Level $8.29 $10.79
Resistance Level $11.19 $14.22
Average True Range (ATR) 0.38 0.09
MACD 0.09 -0.09
Stochastic Oscillator 90.00 13.04

Price Performance

Historical Comparison
ZVRA
EHAB

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: